Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. DRIO
DRIO logo

DRIO News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

DRIO News

DarioHealth Surpasses 100 Scientific Studies, Enhancing Digital Health Impact

Jan 21 2026PRnewswire

DarioHealth Launches DarioIQ™ AI Platform for Initial Hypertension Users

Dec 10 2025PRnewswire

DarioHealth's Digital Nudges Significantly Lower Hypertension Outcomes

Dec 04 2025Newsfilter

DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year

Nov 24 2025PRnewswire

DarioHealth Corp. Reports Reduced Losses in Q3

Nov 13 2025NASDAQ.COM

DarioHealth Unveils New Findings Showing Major Decrease in Medical Expenses for Employers Utilizing Its Digital Health Platform

Nov 12 2025Newsfilter

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of DarioHealth Corp. (NASDAQ: DRIO)

Oct 29 2025PRnewswire

DarioHealth Seeks Approval to Offer 2.71 Million Shares of Common Stock for Shareholders

Oct 21 2025SeekingAlpha

DRIO Events

12/02 08:11
DarioHealth Secures 34 New Employer Clients, Exceeding 2025 Target by 98%
DarioHealth announced that it has secured 34 new employer clients in the past two weeks, reaching a total of 79 clients signed year-to-date, exceeding its 2025 target of 40 new clients by 98%. These new agreements, which collectively represent tens of thousands of covered lives, further validate Dario's strong penetration, stickiness and repeatability in the mid-size employer market. Revenue from these 34 new client signings is expected to begin in the first quarter of 2026.
11/24 08:09
DarioHealth Reveals Study Publication in JMIR Regarding Digital Health Platform
DarioHealth (DRIO) announced the publication of a new peer-reviewed study in the Journal of Medical Internet Research, JMIR, evaluating healthcare utilization and medical costs among Dario users compared to matched non-users receiving usual care. The study, "Effects of a Digital Health Intervention for Adults with Type 2 Diabetes Mellitus on Health Care Resource Use and Health Care Charges in the United States: Retrospective Cohort Study," was not authored by Dario, but rather conducted by researchers at Sanofi (SNY) and Symphony Health. Across multiple measures of healthcare utilization, charges and estimated costs, Dario users demonstrated consistently lower burden compared to a matched group receiving usual care: 23.5% lower inpatient hospitalization rates; 9.3% lower all-cause healthcare resource utilization; 26% lower all-cause HCRU charges; Estimated gross cost savings of $5,077 per patient per year based on standard cost-to-charge conversion methodologies; Shorter inpatient lengths of stay; Lower 30-day readmission rates; A strong dose-response relationship, with more frequent engagement on the Dario platform associated with fewer inpatient and ER events

DRIO Monitor News

No data

No data

DRIO Earnings Analysis

No Data

No Data

People Also Watch